Share Price:

APNASPENAspen Pharmacare Hldgs9894210 (2.17%)

Aspenโ€™s response to the reported Competition Commission investigation

Durban – Media reports that the Competition Commission has decided to take up the Democratic Allianceโ€™s request to investigate the alleged anti-competitive conduct of Aspen Pharmacare (โ€œAspenโ€) in South Africa, in its preliminary investigation into the pharmaceutical sector, has reference. Aspen welcomes the process and the opportunity to categorically set aside such allegations of anti-competitive… Continue reading Aspenโ€™s response to the reported Competition Commission investigation

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.